Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H28ClF2N3O |
| Molecular Weight | 495.991 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C(C=C1)C(CCCN2CCC(CC2)N3C(=O)NC4=CC(Cl)=CC=C34)C5=CC=C(F)C=C5
InChI
InChIKey=JCZYXTVBWHAWLL-UHFFFAOYSA-N
InChI=1S/C28H28ClF2N3O/c29-21-7-12-27-26(18-21)32-28(35)34(27)24-13-16-33(17-14-24)15-1-2-25(19-3-8-22(30)9-4-19)20-5-10-23(31)11-6-20/h3-12,18,24-25H,1-2,13-17H2,(H,32,35)
| Molecular Formula | C28H28ClF2N3O |
| Molecular Weight | 495.991 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Clopimozide is a typical antipsychotic drug, developed by Janssen Pharmaceutica. Clopimozide belongs to diphenylbutylpiperidine class of neuroleptics, and possess an extremely long duration of action. The drug acts by binding to dopamine receptors and by inhibition of calcium channels. In a clinical trial, clopimozide exhibited a marked effect on schizophrenic target symptoms, with an absence of sedation and a low degree of extrapyramidal side-effects. Despite positive results, the drug was never marketed.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:21:56 GMT 2025
by
admin
on
Mon Mar 31 18:21:56 GMT 2025
|
| Record UNII |
7C6TA32SD2
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66883
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
53179-12-7
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
Clopimozide
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
65449
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
100000083998
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
SUB06740MIG
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
3783
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104161
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
7C6TA32SD2
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
335305
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
C77571
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY | |||
|
DTXSID60201238
Created by
admin on Mon Mar 31 18:21:57 GMT 2025 , Edited by admin on Mon Mar 31 18:21:57 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |